BY OUR PLATFORMS
BY THERAPEUTIC AREA
24 September 2015
BIOEurope ® 2015 international life news partnering conference, held in Munich, Germany, November 2–4, 2015, expects over 3,300 delegates representing investors, biotech innovators and pharmaceutical executives from the global drug development industry.Another big draw of BIO-Europe 2015 will be the high-caliber presenting companies attending. Over 150 biotech, midsize pharma, next generation and academic-phase companies are expected to present and an estimated 4,000 licensing opportunities will be on offer at the event. Leading pharmaceutical companies sponsoring the event send teams of scouts to BIO-Europe to engage with new and innovative products, ideas and companies. Large drug development firms in attendance and ready to partner include:
AbbVie, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, GSK, Johnson &Johnson, Lilly, Merck, MSD, Novo Nordisk, Pfizer, Roche, Sanofi, Takeda, and more.
BIO-Europe registration numbers are already up and expected to surpass last year’s edition. The 2014 event featured 17,902 one-to-one partnering meetings. Over 3,200 delegates from 1,772 companies representing 54 countries attended. There were 162 company presentations with 4,032 licensing opportunities on offer, and 98 exhibitors at the event.